Euglycemic diabetic ketoacidosis in association with dapagliflozin use after gastric sleeve surgery in a patient with type II diabetes mellitus.
Iouri BanakhRoss KungSachin GuptaKati MatthiessonRavindranath TiruvoipatiPublished in: Clinical case reports (2019)
Sodium-glucose cotransporter 2 inhibitors (SGLT2Is) can be associated with euglycemic diabetic ketoacidosis (eDKA). Severe metabolic acidosis with extreme electrolyte abnormalities can occur with nonsignificant blood glucose elevations in SGLT2I-treated patients. Additional risk factors for eDKA include prolonged fasting, major illness, large weight loss, and reductions in insulin doses.
Keyphrases
- blood glucose
- glycemic control
- type diabetes
- weight loss
- newly diagnosed
- end stage renal disease
- ejection fraction
- minimally invasive
- bariatric surgery
- wound healing
- prognostic factors
- insulin resistance
- blood pressure
- ionic liquid
- patient reported outcomes
- metabolic syndrome
- solid state
- surgical site infection
- ion batteries